Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test in UAE | 2800 AED | Next-Generation Sequencing (NGS) at DNA Labs UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS processing.

Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain, VIP Mobile Phlebotomy.

Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed clinicians.

Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test is a high-fidelity next-generation sequencing assay that detects pathogenic variants in the LEMD3 gene, confirming the syndromic diagnosis of dermatofibrosis lenticularis disseminata and osteopoikilosis. This test assists dermatologists and geneticists in differentiating benign osteopoikilosis from sclerotic metastases, guiding personalized management.

Feature Our Test Closest Alternative (Sanger Sequencing)
Precision 99.9% sensitivity, whole-gene coverage Limited to exonic regions, may miss deep intronic variants
Method NGS (Next Generation Sequencing) with proprietary bioinformatics Capillary electrophoresis-based single-gene analysis
Turnaround Time 3–4 weeks 4–6 weeks

Physician Insight & Safety Protocols

“As a DHA-licensed Consultant Medical Geneticist, I emphasize that a positive LEMD3 variant must be correlated with a thorough dermatological examination and skeletal survey to confidently diagnose Buschke-Ollendorff syndrome. This test is a powerful diagnostic aid, but clinical correlation remains paramount, especially to distinguish benign osteopoikilosis from more ominous sclerotic bone disorders.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory

⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing clinical care.

Exclusion Criteria & Red Flags

  • Exclusion: Individuals unable to provide informed consent; minors without legal guardian consent (as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
  • Exclusion: Patients with acute febrile illness or severe systemic infection.
  • Red Flag: Rapidly developing painful skin nodules or pathological fractures require immediate clinical evaluation, not elective genetic testing.
  • Red Flag: Neurological symptoms (e.g., cranial nerve deficits) in the context of osteopoikilosis may indicate a more complex syndrome — seek urgent specialist referral.

Patient FAQ & Clinical Guidance

1. What does this test detect?

This DNA test identifies pathogenic mutations in the LEMD3 gene causing Buschke-Ollendorff syndrome, an autosomal dominant condition marked by skin elastomas and osteopoikilosis.

2. How is the sample collected?

A DHA-licensed phlebotomist collects a simple blood sample or buccal swab at your home; no fasting or special preparation is needed.

3. What is the turnaround time?

Results are delivered within 3 to 4 weeks and include a comprehensive genetic counselling session to interpret the findings clearly.

UAE Regulatory & Data Privacy Adherence

This genetic test is performed under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143) and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored securely, and handled in strict compliance with UAE health data privacy frameworks. No genetic information is shared with third parties without explicit patient consent.

Clinical & Logistical Metadata

Test Name LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3–4 weeks
Sample Type / Matrix Whole Blood or Buccal Swab
Methodology Used Next-Generation Sequencing (NGS) – Whole Gene Sequencing
ICD-10-CM Code Q78.8
LOINC Code 101368-6
DHA Facility License & Laboratory Address DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians